Facebook
X
LinkedIn
Forward
Gene Therapy for Sickle Cell Disease
ACTIVITY DESCRIPTION
This patient‑led interview offers a compelling perspective on the real‑world impact of gene therapy for sickle cell disease, highlighting both dramatic physical improvements and the psychological and social adjustments that can follow transformative treatment. Through the patient’s lived experience, learners gain insight into how gene therapy may redefine identity, daily functioning, and long‑term expectations for health. The interview emphasizes the importance of patient‑centered communication, listening to patient expertise, and supporting ongoing mental and emotional adaptation as part of comprehensive, team‑based care.
Provided by
This activity is provided by Optum Health Education.
Commercial support
There was no commercial support received for this activity.
Target Audience
This activity has been designed to meet the educational needs of nurses, nurse practitioners, pharmacists, pharmacy technicians, PAs, physicians, psychologists and other health care professionals.
Learning Objectives
At the end of this educational activity, participants should be able to:
- Recognize the profound physical, psychological, and social transitions experienced by patients following gene therapy and consider patient‑centered, collaborative approaches to support long‑term adjustment, mental well‑being, and care planning.
Faculty
Jimi Olaghere
Tech Entrepreneur, Sickle Cell Disease Patient Advocate
Gene Therapy Recipient
Jimi Olaghere is a CASGEVY® recipient who has developed a keen interest in the advancements of cell and gene therapies since his transformative participation in the groundbreaking clinical trial.
He is passionate about the positive impact these therapies can have on patients in need and has become a staunch advocate for increased accessibility of gene therapies for sickle cell disease (SCD) patients worldwide.
Planners
Elizabeth Albert, MD
Clinical Manager
Optum Health Education
Sarah Chart, RN
Sr. Director Healthcare Optimization & Strategy
Optum Health Education
Sara L. Fleszar, PharmD, BCOP
Senior Clinical Oncology Pharmacist
Whole Health Solutions
Optum Health
Rebecca Gleason, RN, CCM
Clinical Manager
Optum Health Education
Lisa Latts, MD, MSPH, MBA, FACP
Chief Medical Officer
Optum Behavioral Health Solutions & Optum Health Solutions
Optum Health Clinical Excellence
Optum
Jaime Murillo, MD
Senior Vice President and Chief Medical Officer
Medical Affairs
UnitedHealth Group
Sam Nordberg, PhD
Chair of Psychiatry and Behavioral Health
Optum Massachusetts
Disclosures of relevant financial relationships
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, Optum Health Education (OHE) requires all those in control of educational content to disclose their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are defined by the ACCME as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. Individuals must disclose all financial relationships, regardless of the amount, with ineligible companies and regardless of their view of the relevance of the relationship to the education. OHE ensures that the content is independent of commercial bias.
The activity faculty or planners have no financial relationships to disclose.
Accreditation statement
In support of improving patient care, this activity has been planned and implemented by Optum Health Education and Optum Health. Optum Health Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.
Credit designation statements
This activity was planned by and for the health care team, and learners will receive .25 Interprofessional Continuing Education (IPCE) credits for learning and change.
Physicians
Optum Health Education designates this enduring activity for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PAs
The American Academy of PAs (AAPA) accepts credit from organizations accredited by the ACCME.
Pharmacists/Pharmacy technicians
This activity is approved for .25 contact hours (0.025 CEUs) in states that recognize ACPE.
Attending the full program will earn .25 contact hours (0.025 CEUs).
Unique activity number: JA0007123-0000-26-010-H01-P/T
Nurses
The participant will be awarded up to .25 contact hours of credit for attendance and completion of supplemental materials.
Nurse practitioners
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts credit from organizations accredited by the ACCME and ANCC.
Psychologists
Optum Health Education is approved by the American Psychological Association (APA) to offer continuing education for psychologists. Optum Health Education maintains responsibility for this program. .25 CE hour.
Attendance
A certificate of attendance will be provided to learners upon completion of activity requirements, enabling participants to register with licensing boards or associations that have not been preapproved for credits. To apply for credit types not listed above, participants should use the procedure established by the specific organization with which they wish to obtain credit.
Available Credit
- 0.25 ACPE - Pharmacists
- 0.25 ACPE - Pharmacy Technicians
- 0.25 AMA - Physicians
- 0.25 ANCC - Nurses
- 0.25 APA - Psychologists
- 0.25 Attendance - General Attendance
You must be logged into your account to participate in this activity. Get started by clicking “Register” and following the instructions. At the end of the activity, you will be able to view, save or print your certificate of participation. A complete listing of all of your activities can be found under “My Account,” “My Activities.”